Logo Logo

Publications by Zettl, U. K.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 8.

Journal article

Grätz, C.; Gröger, A.; Salmen, A.; Zöller, D.; Schultz, J.; Siller, N.; Lüssi, F.; Fleischer, V.; Bellenberg, B.; Berthele, A.; Biberacher, V.; Havla, J.; Hecker, M.; Hohlfeld, R.; Infante-Duarte, C.; Kirschke, J. S.; Kümpfel, T.; Linker, R.; Paul, F.; Pfeuffer, S.; Sämann, P.; Weber, F.; Zettl, U. K.; Jahn-Eimermacher, A.; Antony, G.; Sergiu, G.; Wiendl, H.; Hemmer, B.; Mühlau, M.; Lukas, C.; Gold, R.; Lill, C. M.; Zipp, F. (2017): Association of smoking but not HLA-DRB1*15:01, APOE, or body mass index with brain atrophy in early multiple sclerosis. In: Multiple Sclerosis Journal, Vol. 23: pp. 184-185

Bismarck, O. von; Dankowski, T.; Antony, G.; Ambrosius, B.; Ziegler, A.; Zipp, F.; Tackenberg, B.; Bergh, F. Then; Tumani, H.; Kümpfel, T.; Stangel, M.; Heesen, C.; Wildemann, B.; Paul, F.; Bayas, A.; Warnke, C.; Weber, F.; Linker, R. A.; Ziemann, U.; Zettl, U. K.; Wiendl, H.; Hemmer, B.; Gold, R.; Salmen, A. (2017): Neuropsychological impairment in newly diagnosed early multiple sclerosis: clinical and neuropsychological characterization of a German cohort of 1124 patients. In: Multiple Sclerosis Journal, Vol. 23: pp. 165-166

Gonzalez-Escamilla, G.; Jäckle, J.; Grätz, C.; Fleischer, V.; Kroth, J.; Antony, G.; Bellenberg, B.; Berthele, A.; Biberacher, V.; Gold, R.; Hecker, M.; Hohlfeld, R.; Jahn, A.; Kirschke, J. S.; Kümpfel, T.; Linker, R. A.; Lukas, C.; Mühlau, M.; Pfeuffer, S.; Salmen, A.; Weber, F.; Wiendl, H.; Zettl, U. K.; Meuth, S.; Lill, C. M.; Muthuraman, M.; Zipp, F.; Groppa, S. (2017): Altered grey matter networks in young patients with MS at genetic risk for Alzheimer's disease. In: Multiple Sclerosis Journal, Vol. 23: pp. 167-168

Gasperi, C.; Salmen, A.; Antony, G.; Bayas, A.; Dankowski, T.; Heesen, C.; Kmpfel, T.; Linker, R. A.; Paul, F.; Stangel, M.; Tackenberg, B.; Bergh, F. Then; Tumani, H.; Warnke, C.; Weber, F.; Wiendl, H.; Wildemann, B.; Zettl, U. K.; Ziemann, U.; Zipp, F.; Gold, R.; Hemmer, B. (2017): Intrathecal immunoglobulin synthesis as a predictive marker for disability progression in multiple sclerosis. In: Multiple Sclerosis Journal, Vol. 23: pp. 301-303

Rommer, P. S.; Dörner, T.; Freivogel, K.; Haas, J.; Kieseier, B. C.; Kümpfel, T.; Paul, F.; Proft, F.; Schulze-Koops, H.; Schmidt, E.; Wiendl, H.; Ziemann, U.; Zettl, U. K. (2016): Safety and Clinical Outcomes of Rituximab Treatment in Patients with Multiple Sclerosis and Neuromyelitis Optica: Experience from a National Online Registry (GRAID). In: Journal of Neuroimmune Pharmacology, Vol. 11, No. 1: pp. 1-8

Gasperi, C.; Krysta, A.; Antony, G.; Bayas, A.; Gold, R.; Heesen, C.; Kümpfel, Tania; Linker, R. A.; Paul, F.; Stangel, M.; Tackenberg, B.; Bergh, F. Then; Tumani, H.; Warnke, C.; Weber, F.; Wick, W.; Wiendl, H.; Zettl, U. K.; Ziemann, U.; Zipp, F.; Buck, D.; Hemmer, B. (2016): Genetic variants associated with intrathecal synthesis of IgG, IgM and IgA in multiple sclerosis. In: Multiple Sclerosis Journal, Vol. 22: pp. 486-487 [PDF, 80kB]

Schrewe, L.; Lill, C. M.; Liu, T.; Salmen, A.; Gerdes, L. A.; Guillot-Noel, L.; Akkad, D. A.; Blaschke, P.; Graetz, C.; Hoffjan, S.; Kroner, A.; Demir, S.; Boehme, A.; Rieckmann, P.; El Ali, A.; Hagemann, N.; Hermann, D. M.; Cournu-Rebeix, I.; Zipp, F.; Kümpfel, Tania; Buttmann, M.; Zettl, U. K.; Fontaine, B.; Bertram, L.; Gold, R.; Chan, A. (2015): Investigation of sex-specific effects of apolipoprotein E on severity of EAE and MS. In: Journal of Neuroinflammation 12:234 [PDF, 908kB]

Limmroth, V.; Malessa, R.; Zettl, U. K.; Koehler, J.; Japp, G.; Haller, P.; Elias, W.; Obhof, W.; Viehöver, A.; Meier, U.; Brosig, A.; Hasford, Joerg; Putzki, N.; Kalski, G.; Wernsdörfer, C. (2007): Quality Assessment in Multiple Sclerosis Therapy (QUASIMS): A comparison of interferon beta therapies for relapsing-remitting multiple sclerosis. In: Journal of Neurology, Vol. 254, No. 1: pp. 67-77

This list was generated on Thu Jan 21 03:35:11 2021 CET.